Abstract
Traditional drug discovery is a time intense, expensive, and complicated procedure. The amalgamation of computer-aided drug design (CADD) and experimental processes can make the whole drug discovery process rational, time efficient, and economical. CADD has two major workflows. One is ligand-based drug design (LBDD) where researchers work with query molecules (ligands), which can be a potential drug for a specific disease. Researchers can check ligands for diverse physicochemical properties and predict their activity against specific diseases. Alternatively, structure-based drug design (SBDD) utilizes protein and enzyme/receptor information and their 3D structures to find the key binding interaction of a prospective drug with specific amino acids. Overall, the CADD approach is highly dependent on applications of commercial and open-source software. With the availability of high-performance computers, supercomputers, cloud-based computing systems, and open-access codes from Github, the CADD process has become extremely viable and effective in terms of reliable drug design and discovery. This chapter discusses the major available tools and software required in different steps of CADD. The provided information can be a valuable resource for the beginners and experienced researchers in the arenas of drug design, computational modeling, chemoinformatics, and medicinal chemistry.
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
More From: Cheminformatics, QSAR and Machine Learning Applications for Novel Drug Development
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.